-
Uncategorized2 months ago
Recessive Neurodevelopmental Disorder Identified Is the Most Prevalent Ever Discovered
Researchers headed by a team at the Icahn School of Medicine at Mount Sinai have identified and described a previously unknown recessive neurodevelopmental disorder (NDD) that...
-
Uncategorized2 months ago
FDA identifies eight deaths tied to Amgen’s Tavneos
FDA identifies eight deaths tied to Amgen's Tavneos
-
Uncategorized2 months agoSTAT+: The HSA industry makes its MAHA pitch
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your...
-
Uncategorized2 months ago
A new way to sell weight loss drugs?
A new way to sell weight loss drugs?
-
Uncategorized2 months ago
Advancing the Manufacture of Patient Accessible Cell and Gene Therapies at Place-of-Care
A partnership involving a medical school, a non-profit organization, and a biotech company have formed a partnership for the development and manufacture of an accessible and...
-
Uncategorized2 months agoLilly beefs up neuroscience pipeline with $6.3B Centessa buyout
The deal secures two sleep disorder drugs that would fill a hole in the company’s portfolio and intensify a competition with Takeda and Eisai.
-
Uncategorized2 months ago
Colorado biotech Ambrosia lands $100M for oral GLP-1
Colorado biotech Ambrosia lands $100M for oral GLP-1
-
Uncategorized2 months ago
Astellas doesn’t pick up AviadoBio’s gene therapy, but nonprofit funding will move it forward
In a sign of the times for gene therapy, Astellas did not take up its option on AviadoBio’s frontotemporal dementia treatment, the UK biotech company disclosed...
-
Uncategorized2 months ago
Celiac Disease Study Reveals Fiber Benefits Depend on Gut Microbiome
The autoimmune disorder celiac disease results in mucosal inflammation and injury of the small intestine, driven by dietary gluten, resulting in a wide range of varied...
-
Uncategorized2 months agoSTAT+: Baby KJ scientists hit road bump in quest to scale custom gene editor
The scientists behind treating Baby KJ say they’ve hit a stumbling block in their efforts to create more custom gene editing treatments for children with rare...
STAT+: Up and down the ladder: The latest comings and goings
FDA imposes import alert on Indian plant after inspectors flag GMP failings
